Mesoblast Ltd SEC filings MEOBF

Mesoblast Ltd has 598 filings in SEC EDGAR's recent list, going back to Nov 8, 2005. Its latest annual report, Form 20-F, was filed on Aug 27, 2026 for the period ended Jun 30, 2026. The most recent current report (Form 6-K) was filed on Nov 3, 2026. The company's fiscal year ends on June 30.

Form Description Filed Period
20-F Annual report (foreign issuer) Aug 27, 2026 Jun 30, 2026
20-F Annual report (foreign issuer) Aug 29, 2025 Jun 30, 2025
20-F Annual report (foreign issuer) Aug 29, 2024 Jun 30, 2024
20-F Annual report (foreign issuer) Aug 31, 2023 Jun 30, 2023
20-F Annual report (foreign issuer) Aug 31, 2022 Jun 30, 2022
20-F Annual report (foreign issuer) Aug 31, 2021 Jun 30, 2021
20-F Annual report (foreign issuer) Sep 3, 2020 Jun 30, 2020
20-F Annual report (foreign issuer) Sep 9, 2019 Jun 30, 2019
20-F Annual report (foreign issuer) Aug 31, 2018 Jun 30, 2018
20-F Annual report (foreign issuer) Aug 30, 2017 Jun 30, 2017
20-F Annual report (foreign issuer) Aug 25, 2016 Jun 30, 2016
ARS Annual report to shareholders Oct 16, 2008 Jun 30, 2008
ARS Annual report to shareholders Sep 17, 2007 Jun 30, 2007
ARS Annual report to shareholders Oct 16, 2006 Jun 30, 2006
ARS Annual report to shareholders Nov 8, 2005 Jun 30, 2005

Showing 15 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
MESO (Nasdaq), MEOBF (OTC)
Fiscal year ends
June 30
Incorporated in
Australia
Headquarters
Melbourne, Victoria, Australia
SEC filer status
Large accelerated filer
SEC CIK
1345099

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.